Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Previously, the patient was seen at his oncology clinic for evidence of cancer progression on his current chemotherapy, rituximab and polatuzumab vedotin, due to an increase in the growth of a bulky tumor on the patients back ( Figure 2 ) The patient was urgently started on a new chemotherapy regimen consisting of ifosfamide, carboplatin and etoposide
What they're saying: "It is statistically significant, and the consequences of hypotension can be terrible
Updated October 2014
R.Del ValleC
The options may be chosen on the product page Thymosin alpha 1 $50.00 $1,600.00Price range: $50.00 through $1,600.00Select options This product has multiple variants
US$ 24.75
US$ 20.31
US$ 25.10
US$ 27.33
